Displaying items by tag: department of neurology

UAB has received prestigious designation as a Comprehensive Stroke Center from the Joint Commission and American Heart Association.
Research to identify a new approach to treat Alzheimer’s disease gets new funding after a pilot grant from the Alabama Drug Discovery Alliance.
UAB neurology researcher Kristen Triebel gets substantial American Cancer Society grant to investigate the ability of patients to understand, choose and consent to treatment.

Best of 2014 2

The first patient in the Southeast to get the RNS responsive neurostimulation seizure-control device implanted in the brain reports dramatic results at UAB.

UAB has launched one of the first clinics in the nation designed to provide healthy adults with an assessment of their risk for Alzheimer’s disease.
A ramped-up immune response may play a major role in autism disorders, according to a new study from UAB and Johns Hopkins.
A new UAB study reports on a potential new treatment for frontotemporal dementia, the second most common type after Alzheimer’s disease.

UAB researchers present warning signs that can be seen when an older adult begins to lose the ability to manage finances – which could indicate dementia.

Philanthropic support has enabled the UAB Department of Neurology to make huge strides in knowledge of diseases such as Parkinson’s.

The eye is a window to the brain; scientists discover early signs of dementia in changes to neurons in the eye’s retina.

UAB is the first medical center in the Southeast to implant a new type of electrical stimulator to control seizures in patients with epilepsy.
Research in personalized medicine, health informatics and genomic medicine spans disciplines and will impact the treatment of many diseases.
New drugs to slow or even prevent Parkinson’s could be in human studies as early as 2015.
Anthony Nicholas, M.D., associate professor in the Department of Neurology at the University of Alabama at Birmingham, is a co-editor of the first textbook on the subject of protein deimination in human health and disease.
A new UAB clinic can predict risk for developing Alzheimer’s disease and offer strategies to reduce that risk.
As part of its ongoing Science, Communication and Innovation talks, Lucas Pozzo-Miller will speak about Rett syndrome.
A new NIH grant could allow researchers to better predict risk factors for patients using blood-thinners by examining the influence of genes, lifestyle, clinical factors and environment.
Page 10 of 13